ReviewNature reviews. Clinical oncology2022

Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges.

Imran Noorani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.